Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor-specific Fab immunogene

被引:7
作者
Ohtake, Y
Chen, JB
Gamou, S
Takayanagi, A
Mashima, Y
Oguchi, Y
Shimizu, N
机构
[1] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Kyorin Univ, Sch Hlth Sci, Dept Biol, Tokyo 1928508, Japan
[3] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 04期
关键词
gene therapy; melanoma; anti-EGF receptor antibody; endocytosis; immunogene;
D O I
10.1111/j.1349-7006.1999.tb00770.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Fab fragment of monoclonal antibody B-4G7 against human epidermal growth factor (EGF receptor was conjugated with cationic poly-L-lysine and the resulting conjugate was further complexed with reporter genes or therapeutic genes. This Fab/DNA, complex was designated as ''Fab limmunogene." The Fab immunogene transfer in vitro was mediated through the EGF receptors in two melanoma cell lines. The frequency of cells expressing beta-galactosidase (beta-Gal) reporter gene was approximately 1%. The induction of suicide effects after Fab immunogene transfer of herpes simplex virus thymidine kinase (TK) or Escherichia coli cytosine deaminase (CD) gene was quite remarkable, and the growth of melanoma cells was inhibited for only 7 days in the presence of ganciclovir (GCV) or 5-fluorocytosine (5-FC). Similarly when melanoma cells treated in vitro with the Fab immunogene carrying TK or CD were transplanted into the back of nude mouse, subsequent systemic administration of GCV or 5-FC effectively suppressed the growth of tumors, indicating the occurrence of in vivo suicide effects.
引用
收藏
页码:460 / 468
页数:9
相关论文
共 34 条
[1]   DENDRITIC CELLS GENERATED FROM PERIPHERAL-BLOOD TRANSFECTED WITH HUMAN TYROSINASE INDUCE SPECIFIC T-CELL ACTIVATION [J].
ALIJAGIC, S ;
MOLLER, P ;
ARTUC, M ;
JURGOVSKY, K ;
CZARNETZKI, BM ;
SCHADENDORF, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3100-3107
[2]   MONOCLONAL-ANTIBODY THAT IMMUNOREACTS WITH A SUBCLASS OF HUMAN RECEPTORS FOR EPIDERMAL GROWTH-FACTOR [J].
BEHZADIAN, MA ;
SHIMIZU, N .
CELL STRUCTURE AND FUNCTION, 1985, 10 (03) :219-232
[3]   IN-VITRO EVIDENCE THAT METABOLIC COOPERATION IS RESPONSIBLE FOR THE BYSTANDER EFFECT OBSERVED WITH HSV TK RETROVIRAL GENE-THERAPY [J].
BI, WL ;
PARYSEK, LM ;
WARNICK, R ;
STAMBROOK, PJ .
HUMAN GENE THERAPY, 1993, 4 (06) :725-731
[4]   BIOLOGICAL RESPONSE MODIFIERS IN MELANOMA [J].
BRIDGEWATER, JA ;
GORE, ME .
BRITISH MEDICAL BULLETIN, 1995, 51 (03) :656-677
[5]  
Chen JB, 1998, CANCER GENE THER, V5, P357
[6]   INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].
CULVER, KW ;
RAM, Z ;
WALLBRIDGE, S ;
ISHII, H ;
OLDFIELD, EH ;
BLAESE, RM .
SCIENCE, 1992, 256 (5063) :1550-1552
[7]   INCREASING EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN MELANOCYTIC TUMOR PROGRESSION [J].
DEWIT, PEJ ;
MORETTI, S ;
KOENDERS, PG ;
WETERMAN, MAJ ;
VANMUIJEN, GNP ;
GIANOTTI, B ;
RUITER, DJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (02) :168-173
[8]   DETECTION OF EPIDERMAL GROWTH-FACTOR RECEPTORS AND E-CADHERINS IN THE BASOLATERAL MEMBRANE OF A431 CELLS BY LASER SCANNING FLUORESCENCE MICROSCOPY [J].
FUKUYAMA, R ;
SHIMIZU, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (01) :8-11
[9]   HYDROGEN-PEROXIDE PREFERENTIALLY ENHANCES THE TYROSINE PHOSPHORYLATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
GAMOU, S ;
SHIMIZU, N .
FEBS LETTERS, 1995, 357 (02) :161-164
[10]  
GUTMAN M, 1994, ANTICANCER RES, V14, P1759